Full Press Release Details
CAMBRIDGE, Mass. , April 19, 2023 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL ), a clinical-stage biopharmaceutical company focused on creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced that James Porter , Ph.D., Chief Executive Officer, and Alexandra Balcom , Chief Financial Officer, will participate in a fireside chat during the Stifel 2023 Virtual Targeted Oncology Days on Wednesday, April 26, 2023 , at 1:30 p.m. ET .
A live webcast will be available in the Investors section of the company's website at www.nuvalent.com , and archived for 30 days following the presentation.
SOURCE Nuvalent, Inc.